(19)
(11) EP 2 875 828 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
24.07.2019 Bulletin 2019/30

(45) Mention of the grant of the patent:
01.05.2019 Bulletin 2019/18

(21) Application number: 13766388.6

(22) Date of filing: 19.07.2013
(51) International Patent Classification (IPC): 
A61K 39/35(2006.01)
A61P 37/08(2006.01)
 A61K 39/36(2006.01)
(86) International application number:
PCT/ES2013/070527
(87) International publication number:
WO 2014/013123 (23.01.2014 Gazette 2014/04)

(54)

COMPOSITION FOR INTRADERMAL ADMINISTRATION OF ALLERGOIDS

ZUSAMMENSETZUNG ZUR INTRADERMALEN VERABREICHUNG VON ALLERGOIDEN

COMPOSITION POUR L'ADMINISTRATION INTRADERMIQUE D'ALLERGOÏDES

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 20.07.2012 ES 201231168
08.03.2013 ES 201330335

(43) Date of publication of application:
27.05.2015 Bulletin 2015/22

(73) Proprietor: Diater, Laboratorio de Diagnóstico y Aplicaciones Terapéuticas, S.A.
28918 Leganés, Madrid (ES)

(72) Inventors:
  • PALACIOS PELÁEZ, Ricardo
    28918 Leganés Madrid (ES)
  • RODRÍGUEZ GIL, David
    28918 Leganés Madrid (ES)
  • ALCOVER DÍAZ, Javier
    28918 Leganés Madrid (ES)
  • PINEDA DE LA LOSA, Fernando
    28918 Leganés Madrid (ES)

(74) Representative: ABG Intellectual Property, S.L. 
Avenida de Burgos, 16D Edificio Euromor
28036 Madrid
28036 Madrid (ES)


(56) References cited: : 
EP-A1- 0 782 860
WO-A1-2011/098569
US-A- 4 180 562
US-A- 4 473 495
 WO-A1-2011/026641
GB-A- 1 282 163
US-A- 4 269 764
   
  • MALET A ET AL: "Clinical and immunological effects of immunotherapy with glutaraldehyde modified house dust mite extract", ALLERGOLOGIA ET IMMUNOPATHOLOGIA, GARSI, MADRID, ES, vol. 22, no. 5, 1 September 1994 (1994-09-01), pages 226-232, XP008098988, ISSN: 0301-0546
  • ARTS JOSJE H E ET AL: "Dose-response relationships and threshold levels in skin and respiratory allergy", CRITICAL REVIEWS IN TOXICOLOGY, CRC PRESS, BOCA RATON, FL, US, vol. 36, no. 3, 1 March 2006 (2006-03-01), pages 219-251, XP008166098, ISSN: 1040-8444, DOI: 10.1080/10408440500534149
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).